Reilly Financial Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $13K | Hold |
55
| – | – | ﹤0.01% | 654 |
|
|
2021
Q3 | $16K | Hold |
55
| – | – | ﹤0.01% | 569 |
|
|
2021
Q2 | $19K | Sell |
55
-195
| -78% | -$59.1K | ﹤0.01% | 553 |
|
|
2021
Q1 | $70K | Sell |
250
-575
| -70% | -$155K | 0.01% | 305 |
|
|
2020
Q4 | $202K | Sell |
825
-19
| -2% | -$4.9K | 0.02% | 187 |
|
|
2020
Q3 | $239K | Buy |
844
+19
| +2% | +$5.3K | 0.03% | 167 |
|
|
2020
Q2 | $221K | Buy |
825
+50
| +6% | +$15K | 0.03% | 166 |
|
|
2020
Q1 | $245K | Hold |
775
| – | – | 0.04% | 155 |
|
|
2019
Q4 | $230K | Hold |
775
| – | – | 0.03% | 174 |
|
|
2019
Q3 | $180K | Hold |
775
| – | – | 0.02% | 195 |
|
|
2019
Q2 | $181K | Sell |
775
-37
| -5% | -$8.54K | 0.02% | 189 |
|
|
2019
Q1 | $192K | Sell |
812
-103
| -11% | -$32.4K | 0.02% | 179 |
|
|
2018
Q4 | $275K | Sell |
915
-10
| -1% | -$3.19K | 0.04% | 145 |
|
|
2018
Q3 | $327K | Hold |
925
| – | – | 0.04% | 144 |
|
|
2018
Q2 | $268K | Sell |
925
-16
| -2% | -$4.5K | 0.04% | 150 |
|
|
2018
Q1 | $258K | Sell |
941
-101
| -10% | -$31.4K | 0.04% | 146 |
|
|
2017
Q4 | $332K | Sell |
1,042
-49
| -4% | -$15.7K | 0.05% | 134 |
|
|
2017
Q3 | $342K | Buy |
1,091
+16
| +1% | +$4.74K | 0.05% | 123 |
|
|
2017
Q2 | $292K | Sell |
1,075
-55
| -5% | -$14.5K | 0.04% | 133 |
|
|
2017
Q1 | $309K | Buy |
1,130
+55
| +5% | +$15.6K | 0.05% | 123 |
|
|
2016
Q4 | $305K | Buy |
1,075
+160
| +17% | +$47.4K | 0.05% | 122 |
|
|
2016
Q3 | $286K | Buy |
915
+8
| +0.9% | +$2.37K | 0.05% | 123 |
|
|
2016
Q2 | $219K | Hold |
907
| – | – | 0.04% | 132 |
|
|
2016
Q1 | $236K | Buy |
+907
| New | +$240K | 0.04% | 170 |
|
|
2015
Q4 | – | Sell |
-920
| Closed | -$264K | – | 1218 |
|
|
2015
Q3 | $268K | Hold |
920
| – | – | 0.05% | 153 |
|
|
2015
Q2 | $372K | Buy |
920
+25
| +3% | +$10K | 0.06% | 133 |
|
|
2015
Q1 | $378K | Buy |
895
+20
| +2% | +$7.88K | 0.07% | 135 |
|
|
2014
Q4 | $297K | Hold |
875
| – | – | 0.07% | 116 |
|
|
2014
Q3 | $289K | Hold |
875
| – | – | 0.07% | 96 |
|
|
2014
Q2 | $284K | Hold |
875
| – | – | 0.07% | 95 |
|
|
2014
Q1 | $268K | Hold |
875
| – | – | 0.06% | 101 |
|
|
2013
Q4 | $245K | Sell |
875
-300
| -26% | -$77.6K | 0.06% | 99 |
|
|
2013
Q3 | $289K | Sell |
1,175
-25
| -2% | -$5.59K | 0.08% | 85 |
|
|
2013
Q2 | $260K | Buy |
+1,200
| New | +$256K | 0.08% | 89 |
|
Other funds holding BIIB
Reilly Financial Advisors's BIIB Position: Q4 2021 in Review
Reilly Financial Advisors held its Biogen (BIIB) position steady in Q4 2021 at 55 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #654.
Reilly Financial Advisors first reported a position in BIIB in Q2 2013 and has held it in 34 quarters since. The position peaked at $378K in Q1 2015. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.
- Reilly Financial Advisors held 55 shares of Biogen worth $13K as of Q4 2021.
- Reilly Financial Advisors left its Biogen share count unchanged in Q4 2021.
- Biogen made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #654 holding.
- Reilly Financial Advisors first reported a position in Biogen in Q2 2013 and has held it in 34 quarters since.
- Reilly Financial Advisors's Biogen position peaked at $378K in Q1 2015.
- 1,010 funds tracked by Wall St. Rank held Biogen as of Q4 2021.
Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.